Extrapyramidal effects of SSRI antidepressants
- PMID: 11718183
Extrapyramidal effects of SSRI antidepressants
Abstract
(1) About a hundred detailed reports of extrapyramidal adverse effects linked to a "selective" serotonin reuptake inhibitor (SSRI) antidepressant have been published. (2) The effects include acute dystonia, akathisia, and onset or aggravation of parkinsonism. Late-onset dyskinesias are rare. (3) All SSRIs have been implicated. (4) The annual incidence is unclear. It has been estimated at about 1-2 cases per 1 000 patients. (5) In patients with Parkinson's disease, SSRIs are an alternative to tricyclic antidepressants but can worsen the disease itself.
Similar articles
-
Extrapyramidal reactions and the selective serotonin-reuptake inhibitors.Ann Pharmacother. 1997 Dec;31(12):1481-9. doi: 10.1177/106002809703101208. Ann Pharmacother. 1997. PMID: 9416386 Review.
-
Extrapyramidal Reactions Associated with Serotonergic Antidepressants.Ann Pharmacother. 2015 Oct;49(10):1136-52. doi: 10.1177/1060028015594812. Epub 2015 Jul 16. Ann Pharmacother. 2015. PMID: 26185277 Review.
-
Movement disorders associated with the serotonin selective reuptake inhibitors.J Clin Psychiatry. 1996 Oct;57(10):449-54. doi: 10.4088/jcp.v57n1002. J Clin Psychiatry. 1996. PMID: 8909330 Review.
-
Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports.Ann Clin Psychiatry. 2010 Aug;22(3):148-56. Ann Clin Psychiatry. 2010. PMID: 20680187 Review.
-
Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly.Drugs Aging. 2008;25(6):501-19. doi: 10.2165/00002512-200825060-00004. Drugs Aging. 2008. PMID: 18540689 Review.
Cited by
-
Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic.Ther Clin Risk Manag. 2022 Dec 20;18:1129-1142. doi: 10.2147/TCRM.S360268. eCollection 2022. Ther Clin Risk Manag. 2022. PMID: 36573102 Free PMC article. Review.
-
Tics Induced by Sertraline: Case Report and Literature Review.Mov Disord Clin Pract. 2014 Jun 4;1(3):243-244. doi: 10.1002/mdc3.12044. eCollection 2014 Sep. Mov Disord Clin Pract. 2014. PMID: 30713857 Free PMC article. No abstract available.
-
A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.Curr Neuropharmacol. 2010 Sep;8(3):287-304. doi: 10.2174/157015910792246227. Curr Neuropharmacol. 2010. PMID: 21358978 Free PMC article.